Feline Toxoplasmosis: Neurological Manifestations and Cerebral Involvement

Introduction

Feline toxoplasmosis, caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii, is a globally prevalent protozoal infection in domestic cats (Felis catus). While many infected cats remain subclinical, neurological manifestations represent some of the most severe and diagnostically challenging presentations of the disease. Cerebral involvement, including the formation of granulomatous lesions, can mimic other intracranial pathologies such as neoplasia or inflammatory disease. This article provides an exhaustive review of the neurological manifestations of feline toxoplasmosis, with emphasis on cerebral involvement, pathogenesis, diagnostic imaging, and cytological characterization. The discussion is grounded in a landmark case report documenting the diagnosis of a T. gondii brain granuloma using intraoperative cytology and sequential magnetic resonance imaging (MRI) [1]. For a broader overview of feline toxoplasmosis transmission and general clinical signs, readers are directed to the companion article: Toxoplasmosis in Cats: Transmission Routes for Indoor Cats, Clinical Signs, Diagnostic Blood Testing, and Public Health Concerns.

Etiology and Life Cycle

Toxoplasma gondii is a cyst-forming coccidian parasite with a heteroxenous life cycle. Felids, including domestic cats, serve as the definitive host, supporting the sexual stage of reproduction in the intestinal epithelium and shedding environmentally resistant oocysts in feces [1]. Intermediate hosts, including birds, rodents, and humans, acquire infection through ingestion of oocysts or tissue cysts containing bradyzoites. In the feline host, after primary infection, the parasite disseminates via the bloodstream and lymphatic system, invading nucleated cells throughout the body, including neurons and glial cells in the central nervous system (CNS). The ability of T. gondii to form tissue cysts in the brain is a hallmark of chronic latent infection, and reactivation of these cysts, particularly in immunocompromised animals, leads to necrotizing and granulomatous inflammation [1].

Pathogenesis of Cerebral Toxoplasmosis

Cerebral toxoplasmosis in cats often results from reactivation of latent tissue cysts during periods of immunosuppression, although primary acute encephalitis can also occur. The formation of a brain granuloma, as described in the case report by Falzone et al., represents a specific pathological response characterized by a focal accumulation of macrophages, epithelioid cells, multinucleated giant cells, and lymphocytes surrounding extracellular tachyzoites or cyst fragments [1]. Granulomas can develop in the cerebrum, cerebellum, brainstem, or meninges, leading to focal neurological deficits depending on the anatomical location. The inflammatory response is driven by both Th1-mediated immunity and parasite-derived factors, including the dense granule proteins and rhoptry kinases that modulate host cell signaling. Vasculitis, edema, and perivascular cuffing frequently accompany the granulomatous reaction, contributing to increased intracranial pressure and clinical deterioration [1].

Neurological Manifestations

Cats with cerebral toxoplasmosis present with a wide spectrum of neurological signs, reflecting the multifocal or diffuse nature of the lesions. Common manifestations include seizures (generalized or partial), altered mentation (depression, stupor, or coma), circling, head pressing, ataxia, and proprioceptive deficits [1]. Cranial nerve deficits, such as anisocoria, strabismus, facial nerve paresis, and visual impairment, may also be observed. In the case reported by Falzone et al., a cat presented with progressive neurological deterioration, including seizure activity and behavioral changes, which prompted advanced diagnostic imaging [1]. Focal signs such as hemiparesis or unilateral forebrain signs can occur if a granuloma occupies a specific cortical region. It is important to note that the clinical presentation is not pathognomonic; similar signs are seen in other feline CNS diseases, including feline infectious peritonitis (FIP) and intracranial neoplasia [1].

Diagnostic Imaging and Cytology

Antemortem diagnosis of cerebral toxoplasmosis is challenging. Magnetic resonance imaging (MRI) provides the most detailed characterization of brain lesions. The typical MRI appearance of a T. gondii granuloma includes a well-defined, space-occupying mass that is T2-hyperintense and T1-hypointense or isointense, with variable contrast enhancement patterns reflecting the integrity of the blood-brain barrier and the degree of inflammation [1]. Perilesional edema is common. In the Falzone et al. case, sequential MRI scans documented the evolution of the granuloma, initially appearing as a focal lesion with ring enhancement that later reduced in size following antiprotozoal therapy [1]. However, MRI findings alone cannot distinguish toxoplasmic granuloma from other mass lesions such as meningioma, glioma, or inflammatory granuloma of other etiologies.

Cytological examination of intraoperative samples obtained via stereotactic biopsy or ultrasound-guided aspiration provides definitive diagnosis. In the referenced case, cytology from an intraoperative sample revealed numerous extracellular and intracellular tachyzoites, consistent with acute toxoplasmic encephalitis, along with granulomatous inflammation characterized by epithelioid macrophages and rare multinucleated giant cells [1]. The presence of crescent-shaped tachyzoites, measuring approximately 2-3 µm by 5-7 µm, with a centrally located nucleus, is diagnostic. Immunocytochemical staining using anti-T. gondii antibodies can confirm the identity of the organisms [1].

Diagnostic Decision Tree for Suspected Cerebral Toxoplasmosis

flowchart TD
    A["Cat with neurological signs: seizures, circling, altered mentation"] --> B{Advanced imaging indicated?}
    B -->|Yes| C[MRI brain with and without contrast]
    C --> D{Mass lesion detected?}
    D -->|Yes| E[Consider CSF analysis + serology]
    D -->|No| F["Consider other causes: FIP, neoplasia, metabolic"]
    E --> G{Suggestive of toxoplasmosis?}
    G -->|Yes| H[Intraoperative biopsy or stereotactic aspiration]
    H --> I[Cytology + immunocytochemistry]
    I --> J{Tachyzoites or Toxoplasma antigen?}
    J -->|Positive| K["Diagnosis: cerebral toxoplasmosis"]
    J -->|Negative| L[Consider other granulomatous diseases]
    K --> M["Initiate antiprotozoal therapy: clindamycin + supportive care"]
    M --> N[Serial MRI and clinical re-evaluation]
    N --> O["Monitor response: lesion reduction, clinical improvement"]
    G -->|No| P[Pursue alternative diagnoses]

Differential Diagnoses

The differential diagnosis for a feline patient with intracranial mass lesion and neurological signs is extensive. Key considerations include meningioma, glioma, choroid plexus tumors, and metastatic neoplasia. Inflammatory non-infectious conditions such as granulomatous meningoencephalomyelitis (GME) can also mimic toxoplasmosis. Infectious etiologies other than T. gondii include feline coronavirus (FIP), cryptococcosis, bacterial abscesses, and less commonly, protozoal infections like Neospora caninum or Sarcocystis species [1]. The definitive differentiation requires cytological or histopathological demonstration of the causative agent, as serology and CSF analysis may provide supportive but not confirmatory evidence. In the Falzone et al. case, serology for Toxoplasma IgG and IgM was positive, but CSF PCR was negative, underscoring the importance of tissue sampling for diagnosis [1].

Treatment and Prognosis

The cornerstone of treatment for feline cerebral toxoplasmosis is clindamycin administered orally or parenterally at a dosage of 10-12 mg/kg every 12 hours for a minimum of 4 weeks. Alternative or adjunctive therapies include trimethoprim-sulfonamide combinations, azithromycin, or ponazuril, although clinical efficacy data for cerebral toxoplasmosis specifically are limited [1]. Corticosteroids (e.g., prednisolone at anti-inflammatory doses) may be used cautiously to manage severe cerebral edema, as long as antiprotozoal therapy is concurrent to prevent exacerbation of infection. The prognosis is guarded to fair, depending on the severity of neurological deficits and the promptness of diagnosis. In the case reported by Falzone et al., the cat showed significant clinical improvement following clindamycin therapy, with serial MRI demonstrating resolution of the granuloma over several months [1]. However, residual neurological deficits, including seizure disorders, may persist. Long-term monitoring with repeat imaging and clinical assessment is recommended.

Conclusion

Cerebral toxoplasmosis in cats presents as a complex diagnostic challenge due to its nonspecific clinical and imaging features. The formation of brain granulomas, as documented by Falzone et al., represents a distinct pathological entity that requires a combination of advanced imaging, cytological evaluation, and immunohistochemical confirmation for accurate diagnosis. Intraoperative cytology remains a highly valuable tool for rapid, definitive identification of T. gondii tachyzoites in CNS mass lesions [1]. Clinicians should maintain a high index of suspicion for toxoplasmosis in any feline patient with progressive neurological signs and intracranial mass lesions, particularly when serological evidence of exposure is present. Early initiation of clindamycin therapy can lead to favorable outcomes, but delayed diagnosis carries a poor prognosis.

References

[1] Falzone C, Baroni M, De Lorenzi D, et al. Toxoplasma gondii brain granuloma in a cat: diagnosis using cytology from an intraoperative sample and sequential magnetic resonance imaging. J Small Anim Pract. 2008;49(2):95-99. https://pubmed.ncbi.nlm.nih.gov/17784931/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.